Selective serotonin-reuptake inhibitors for the treatment of hot flashes

被引:8
|
作者
De Sloover Koch, Y
Ernst, ME
机构
[1] Univ Iowa, Div Clin & Adm Pharm, Coll Pharm, Iowa City, IA 52242 USA
[2] Dept Vet Affairs Med Ctr, Ambulatory Care Clin Pharm Specialist, Iowa City, IA USA
关键词
antidepressants; hot flashes; selective serotonin-reuptake inhibitors;
D O I
10.1345/aph.1D512
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the literature evaluating the use of selective serotonin-reuptake inhibitors (SSRIs) for the treatment of hot flashes. DATA SOURCES: Biomedical literature was accessed through MEDLINE (1966-June 2003), MID Consult, and references of reviewed articles. Key search terms used were hot flashes, vasomotor symptoms, antidepressants, and SSRIs. DATA SYNTHESIS: Recent evidence from the Women's Health Initiative precludes the use of traditional hormonal therapy in some women. Nonhormonal therapies are possible options, but conflicting evidence of efficacy exists. CONCLUSIONS: Although further studies are warranted, preliminary data suggest that SSRIs are generally modestly successful in reducing the frequency and severity of hot flashes.
引用
收藏
页码:1293 / 1296
页数:4
相关论文
共 50 条
  • [1] Clastogenicity of selective serotonin-reuptake inhibitors
    Bozkurt, G
    Abay, E
    Ates, I
    Karabogaz, G
    Ture, M
    Savran, FO
    Palanduz, S
    Temocin, K
    Algunes, C
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2004, 558 (1-2) : 137 - 144
  • [2] Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression
    Nieuwstraten, CE
    Dolovich, LR
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1608 - 1613
  • [3] Extrapyramidal reactions and the selective serotonin-reuptake inhibitors
    Caley, CF
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (12) : 1481 - 1489
  • [4] Risk of Fractures with Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants
    Ginzburg, Regina
    Rosero, Enma
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (01) : 98 - 103
  • [5] Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV
    Caballero, J
    Nahata, MC
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) : 141 - 145
  • [6] Adverse event reporting with selective serotonin-reuptake inhibitors
    Hartnell, NR
    Wilson, JP
    Patel, NC
    Crismon, ML
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1387 - 1391
  • [7] Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults
    Jacob, Susan
    Spinler, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (09) : 1618 - 1622
  • [8] Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment
    van Geffen, Erica C. G.
    van Hulten, Rolf
    Bouvy, Marcel L.
    Egberts, Antoine C. G.
    Heerdink, Eibert R.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (02) : 218 - 225
  • [9] The pharmacogenomics of selective serotonin reuptake inhibitors
    Garcia-Marin, Luis M.
    Rabinowitz, Jill A.
    Ceja, Zuriel
    Alcauter, Sarael
    Medina-Rivera, Alejandra
    Renteria, Miguel E.
    PHARMACOGENOMICS, 2022, 23 (10) : 597 - 607
  • [10] Selective serotonin-reuptake inhibitor-induced movement disorders
    Gerber, PE
    Lynd, LD
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (06) : 692 - 698